The small leucine-rich repeat proteoglycans in tissue repair and atherosclerosis

A. Hultgårdh-Nilsson, J. Borén, S. Chakravarti

Research output: Contribution to journalArticle

Abstract

Proteoglycans consist of a protein core with one or more covalently attached glycosaminoglycan (GAG) side chains and have multiple roles in the initiation and progression of atherosclerosis. Here we discuss the potential and known functions of a group of small leucine-rich repeat proteoglycans (SLRPs) in atherosclerosis. We focus on five SLRPs, decorin, biglycan, lumican, fibromodulin and PRELP, because these have been detected in atherosclerotic plaques or demonstrated to have a role in animal models of atherosclerosis. Decorin and biglycan are modified post-translationally by substitution with chondroitin/dermatan sulphate GAGs, whereas lumican, fibromodulin and PRELP have keratan sulphate side chains, and the core proteins have leucine-rich repeat (LRR) motifs that are characteristic of the LRR superfamily. The chondroitin/dermatan sulphate GAG side chains have been implicated in lipid retention in atherosclerosis. The core proteins are discussed here in the context of (i) interactions with collagens and their implications in tissue integrity, fibrosis and wound repair and (ii) interactions with growth factors, cytokines, pathogen-associated molecular patterns and cell surface receptors that impact normal physiology and disease processes such as inflammation, innate immune responses and wound healing (i.e. processes that are all important in plaque development and progression). Thus, studies of these SLRPs in the context of wound healing are providing clues about their functions in early stages of atherosclerosis to plaque vulnerability and cardiovascular disease at later stages. Understanding of signal transduction pathways regulated by the core protein interactions is leading to novel roles and therapeutic potential for these proteins in wound repair and atherosclerosis.

Original languageEnglish (US)
Pages (from-to)447-461
Number of pages15
JournalJournal of Internal Medicine
Volume278
Issue number5
DOIs
StatePublished - Nov 1 2015

Fingerprint

Atherosclerosis
Biglycan
Decorin
Dermatan Sulfate
Wound Healing
Proteins
Keratan Sulfate
Chondroitin Sulfates
Wounds and Injuries
Cell Surface Receptors
Atherosclerotic Plaques
Proteoglycans
Glycosaminoglycans
Innate Immunity
Leucine
Small Leucine-Rich Proteoglycans
Signal Transduction
Intercellular Signaling Peptides and Proteins
Fibrosis
Cardiovascular Diseases

Keywords

  • Atherosclerosis
  • Biglycan
  • Decorin
  • Fibromodulin
  • Lumican
  • Small leucine-rich repeat proteoglycan

ASJC Scopus subject areas

  • Internal Medicine

Cite this

The small leucine-rich repeat proteoglycans in tissue repair and atherosclerosis. / Hultgårdh-Nilsson, A.; Borén, J.; Chakravarti, S.

In: Journal of Internal Medicine, Vol. 278, No. 5, 01.11.2015, p. 447-461.

Research output: Contribution to journalArticle

Hultgårdh-Nilsson, A. ; Borén, J. ; Chakravarti, S. / The small leucine-rich repeat proteoglycans in tissue repair and atherosclerosis. In: Journal of Internal Medicine. 2015 ; Vol. 278, No. 5. pp. 447-461.
@article{6f099ba12cd84255bfdd3037004637f9,
title = "The small leucine-rich repeat proteoglycans in tissue repair and atherosclerosis",
abstract = "Proteoglycans consist of a protein core with one or more covalently attached glycosaminoglycan (GAG) side chains and have multiple roles in the initiation and progression of atherosclerosis. Here we discuss the potential and known functions of a group of small leucine-rich repeat proteoglycans (SLRPs) in atherosclerosis. We focus on five SLRPs, decorin, biglycan, lumican, fibromodulin and PRELP, because these have been detected in atherosclerotic plaques or demonstrated to have a role in animal models of atherosclerosis. Decorin and biglycan are modified post-translationally by substitution with chondroitin/dermatan sulphate GAGs, whereas lumican, fibromodulin and PRELP have keratan sulphate side chains, and the core proteins have leucine-rich repeat (LRR) motifs that are characteristic of the LRR superfamily. The chondroitin/dermatan sulphate GAG side chains have been implicated in lipid retention in atherosclerosis. The core proteins are discussed here in the context of (i) interactions with collagens and their implications in tissue integrity, fibrosis and wound repair and (ii) interactions with growth factors, cytokines, pathogen-associated molecular patterns and cell surface receptors that impact normal physiology and disease processes such as inflammation, innate immune responses and wound healing (i.e. processes that are all important in plaque development and progression). Thus, studies of these SLRPs in the context of wound healing are providing clues about their functions in early stages of atherosclerosis to plaque vulnerability and cardiovascular disease at later stages. Understanding of signal transduction pathways regulated by the core protein interactions is leading to novel roles and therapeutic potential for these proteins in wound repair and atherosclerosis.",
keywords = "Atherosclerosis, Biglycan, Decorin, Fibromodulin, Lumican, Small leucine-rich repeat proteoglycan",
author = "A. Hultg{\aa}rdh-Nilsson and J. Bor{\'e}n and S. Chakravarti",
year = "2015",
month = "11",
day = "1",
doi = "10.1111/joim.12400",
language = "English (US)",
volume = "278",
pages = "447--461",
journal = "Journal of Internal Medicine",
issn = "0954-6820",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - The small leucine-rich repeat proteoglycans in tissue repair and atherosclerosis

AU - Hultgårdh-Nilsson, A.

AU - Borén, J.

AU - Chakravarti, S.

PY - 2015/11/1

Y1 - 2015/11/1

N2 - Proteoglycans consist of a protein core with one or more covalently attached glycosaminoglycan (GAG) side chains and have multiple roles in the initiation and progression of atherosclerosis. Here we discuss the potential and known functions of a group of small leucine-rich repeat proteoglycans (SLRPs) in atherosclerosis. We focus on five SLRPs, decorin, biglycan, lumican, fibromodulin and PRELP, because these have been detected in atherosclerotic plaques or demonstrated to have a role in animal models of atherosclerosis. Decorin and biglycan are modified post-translationally by substitution with chondroitin/dermatan sulphate GAGs, whereas lumican, fibromodulin and PRELP have keratan sulphate side chains, and the core proteins have leucine-rich repeat (LRR) motifs that are characteristic of the LRR superfamily. The chondroitin/dermatan sulphate GAG side chains have been implicated in lipid retention in atherosclerosis. The core proteins are discussed here in the context of (i) interactions with collagens and their implications in tissue integrity, fibrosis and wound repair and (ii) interactions with growth factors, cytokines, pathogen-associated molecular patterns and cell surface receptors that impact normal physiology and disease processes such as inflammation, innate immune responses and wound healing (i.e. processes that are all important in plaque development and progression). Thus, studies of these SLRPs in the context of wound healing are providing clues about their functions in early stages of atherosclerosis to plaque vulnerability and cardiovascular disease at later stages. Understanding of signal transduction pathways regulated by the core protein interactions is leading to novel roles and therapeutic potential for these proteins in wound repair and atherosclerosis.

AB - Proteoglycans consist of a protein core with one or more covalently attached glycosaminoglycan (GAG) side chains and have multiple roles in the initiation and progression of atherosclerosis. Here we discuss the potential and known functions of a group of small leucine-rich repeat proteoglycans (SLRPs) in atherosclerosis. We focus on five SLRPs, decorin, biglycan, lumican, fibromodulin and PRELP, because these have been detected in atherosclerotic plaques or demonstrated to have a role in animal models of atherosclerosis. Decorin and biglycan are modified post-translationally by substitution with chondroitin/dermatan sulphate GAGs, whereas lumican, fibromodulin and PRELP have keratan sulphate side chains, and the core proteins have leucine-rich repeat (LRR) motifs that are characteristic of the LRR superfamily. The chondroitin/dermatan sulphate GAG side chains have been implicated in lipid retention in atherosclerosis. The core proteins are discussed here in the context of (i) interactions with collagens and their implications in tissue integrity, fibrosis and wound repair and (ii) interactions with growth factors, cytokines, pathogen-associated molecular patterns and cell surface receptors that impact normal physiology and disease processes such as inflammation, innate immune responses and wound healing (i.e. processes that are all important in plaque development and progression). Thus, studies of these SLRPs in the context of wound healing are providing clues about their functions in early stages of atherosclerosis to plaque vulnerability and cardiovascular disease at later stages. Understanding of signal transduction pathways regulated by the core protein interactions is leading to novel roles and therapeutic potential for these proteins in wound repair and atherosclerosis.

KW - Atherosclerosis

KW - Biglycan

KW - Decorin

KW - Fibromodulin

KW - Lumican

KW - Small leucine-rich repeat proteoglycan

UR - http://www.scopus.com/inward/record.url?scp=84944687983&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84944687983&partnerID=8YFLogxK

U2 - 10.1111/joim.12400

DO - 10.1111/joim.12400

M3 - Article

C2 - 26477596

AN - SCOPUS:84944687983

VL - 278

SP - 447

EP - 461

JO - Journal of Internal Medicine

JF - Journal of Internal Medicine

SN - 0954-6820

IS - 5

ER -